Considering the pharmacological effect of rebamipide on mucin secretion from goblet cells and the demanding need to develop novel therapies for dry eye, OP decided to reposition rebamipide for the treatment of dry eye. Here, MUC5AC is linked to Keratoconjunctivitis sicca.